Exelixis Inc (EXEL)

Exchange
NASDAQ
Symbol
EXEL
Sector
Trade & Services
Industry
Services-commercial Physical & Biological Research
Description
Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California.
Country
USA

Stock price

At close: September 19, 2025

  • Open
    40.24
  • High
    40.55
  • Low
    39.87
  • Close
    40.10
  • Volume
    7,751,560

Financial ratios

Dec 31, 2024